viral persistence

  1. SNT Gatchaman

    Differences in SARS-CoV-2 antigen persistence in […] systemic autoimmune rheumatic diseases compared to the general population…, 2026, Patel+

    Differences in SARS-CoV-2 antigen persistence in individuals with systemic autoimmune rheumatic diseases compared to the general population: A RECOVER-Adult Cohort Study BACKGROUND Individuals with systemic autoimmune rheumatic diseases (SARDs) are at risk for worse acute and post-acute...
  2. ME/CFS Science Blog

    ME/CFS Science Blog article - Immune findings in ME/CFS

    Link to the article: https://mecfsscience.org/immune-findings-in-me-cfs/
  3. forestglip

    Preprint Persistent SARS-CoV-2 Spike is Associated with Localized Immune Dysregulation in Long COVID Gut Biopsies, 2026, Abraham Soria et al

    Persistent SARS-CoV-2 Spike is Associated with Localized Immune Dysregulation in Long COVID Gut Biopsies [Line breaks added] Abstract SARS-CoV-2 persistence is a proposed driver of Long COVID (LC), but the in-situ relationship between residual viral antigen and immune dysregulation remains...
  4. SNT Gatchaman

    Persistent Gut-Immune Axis dysregulation in long-term Post-COVID Syndrome…, 2026, Augustin+

    Persistent Gut-Immune Axis dysregulation in long-term Post-COVID Syndrome: Insights from a prospective, observational, cross-sectional case-control study Post-COVID syndrome (PCS) is a complex condition that can emerge after recovery from SARS-CoV-2 infection, even in young, healthy...
  5. SNT Gatchaman

    Preprint A phase 2a double-blind, placebo-controlled randomized trial of the SARS-CoV-2-specific monoclonal antibody AER002…, 2026, Peluso+

    A phase 2a double-blind, placebo-controlled randomized trial of the SARS-CoV-2-specific monoclonal antibody AER002 in people with Long COVID Long COVID is a disabling chronic illness with no proven treatments. Persistence of SARS-CoV-2 has been proposed as a biological driver of the disease...
  6. SNT Gatchaman

    CD169+ and HLA-DR+ extracellular vesicles are highly represented in human plasma and dynamically expressed in [Covid & LC], 2026, Fanelli+

    CD169+ and HLA-DR+ extracellular vesicles are highly represented in human plasma and dynamically expressed in SARS-CoV-2 infection and long COVID-associated sequelae INTRODUCTION Elevated inflammation and immune dysregulation are the main consequences of severe acute respiratory syndrome...
  7. Mij

    Serum extracellular vesicle RNA profiles in long COVID: insights from exercise-induced gene modulation, 2026, Asghar Abbasi et al

    Abstract The Persistence of SARS-CoV-2 in tissues has been proposed as a driver of prolonged symptoms in long COVID. Pulmonary rehabilitation with exercise training is a well-established intervention for improving symptoms, functional capacity, and inflammation in chronic cardiorespiratory...
  8. SNT Gatchaman

    SARS-CoV-2 infection is associated with hypothalamic orexin suppression and persistent cortical NeuN attenuation, 2026, Yoon et al.

    This is the preprint. Go to post #9 for the published paper Disruption of the hypothalamic orexin system links SARS-CoV-2 infection to persistent cortical neuronal pathology Long COVID frequently presents with persistent neurological symptoms, including cognitive impairment, fatigue, and...
  9. SNT Gatchaman

    Preprint Post-COVID impairment of memory T cell responses to community-acquired pathogens can be rectified by activating cellular metabolism, 2026, Carroll+

    Post-COVID impairment of memory T cell responses to community-acquired pathogens can be rectified by activating cellular metabolism Infection rates involving bacterial and viral pathogens have increased precipitously after the COVID-19 pandemic. While it has been speculated that higher...
  10. forestglip

    [Abstract] Broadly neutralizing antibodies to SARS-CoV-2 in Long COVID areassociated with viral persistence and clinical outcome, 2025, Liu et al

    Broadly neutralizing antibodies to SARS-CoV-2 in Long COVID are associated with viral persistence and clinical outcome Chenyu Liu, Daniel Sanson, Serhan Soylu, Leen Moens, Isabelle Meyts, Marc Jamoulle, Johan Van Weyenbergh [Line breaks added] Abstract Long COVID (also known as post-acute...
  11. John Mac

    Review Mucosal Viruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Missing Piece of the Puzzle? 2025, Carding et al

    Abstract Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating chronic condition without a definitive aetiology, no reliable diagnostic test, and no proven effective treatment. Despite most patients reporting a post-viral onset of illness, findings to date are conflicting...
  12. SNT Gatchaman

    A highly divergent sample from a nearly extinct SARS-CoV-2 lineage in a patient with long-term COVID-19, 2025, Nabieva et al.

    A highly divergent sample from a nearly extinct SARS-CoV-2 lineage in a patient with long-term COVID-19 BACKGROUND Although COVID-19 is primarily an acute disease, there are cases of persistent infection, primarily in immunocompromised patients. It is hypothesized that at least some variants...
  13. J

    No “easy home runs”: Early Long COVID trials of Paxlovid and monoclonal antibodies failed, but the treatments still have potential Sick Times (AER002)

    https://thesicktimes.org/2025/08/12/no-easy-home-runs-early-long-covid-trials-of-paxlovid-and-monoclonal-antibodies-failed-but-the-treatments-still-have-potential/
  14. forestglip

    Trial Report Viral spike antigen clearance and augmented recovery in children with post-COVID [MIS-C] treated with larazotide, 2025, Yonker et al

    Viral spike antigen clearance and augmented recovery in children with post-COVID multisystem inflammatory syndrome treated with larazotide Lael M. Yonker, Abigail S. Kane, Zoe Swank, Lena Papadakis, Victoria Kenyon, Samuel Han, Rosiane Lima, Lauren B. Guthrie, Bryan Alvarez-Carcamo, Manuella...
  15. forestglip

    Possible long COVID biomarker: identification of SARC-CoV-2 related protein(s) in Serum Extracellular Vesicles, 2025, Abbasi et al

    Possible long COVID biomarker: identification of SARC-CoV-2 related protein(s) in Serum Extracellular Vesicles Asghar Abbasi, Ritin Sharma, Nathaniel Hansen, Patrick Pirrotte & William W. Stringer [Snippets from correspondence with no abstract, bolding added] Web | PDF | Infection | Open...
  16. forestglip

    Hypothesis Long Vax is delayed onset Long COVID, 2025, Bunker

    Long Vax is delayed onset Long COVID Thomas Bunker [Line breaks added] Highlights • Long Vax or PCVS is a large constellation of chronic patient-reported symptoms that closely align with those of Long COVID. • SARS-CoV-2 actively suppresses pathogen sensing pathways within infected...
  17. SNT Gatchaman

    COVID-19 induces persistent transcriptional changes in adipose tissue that are not associated with Long COVID, 2025, DeLine-Caballero, Rosen, Blish+

    COVID-19 induces persistent transcriptional changes in adipose tissue that are not associated with Long COVID Soneida DeLine-Caballero; Kalani Ratnasiri; Heping Chen; Seynt Jiro Sahagun; Uma M. Mangalanathan; Trisha R. Barnard; Nicole Turk; Jasmine Yang; Natesh Saini; Ekrem M. Ayhan; Hasiyet...
  18. SNT Gatchaman

    Preprint The Role of SARS-CoV-2 Nucleocapsid Protein Persistence in Inducing Chronic Type I Interferon and Mitochondrial Dysfunction., 2025, Koenig et al.

    The Role of SARS-CoV-2 Nucleocapsid Protein Persistence in Inducing Chronic Type I Interferon and Mitochondrial Dysfunction. Andreas Koenig; Mohammad Quasem; Benjamin Zink; Doniyorbek Abdulla-Zoda; Priyanka Karunanidhi; Karolina Sienko; Christian Geier; Venkatesh Jayaraman; Rabia Malik; Kanza...
  19. SNT Gatchaman

    Characteristic immune cell interactions in livers of children with acute hepatitis revealed by spatial single-cell analysis…, 2025, Röttele+

    Characteristic immune cell interactions in livers of children with acute hepatitis revealed by spatial single-cell analysis identify a possible postacute sequel of COVID-19 Felix Röttele; Andreas Zollner; Carolin Mogler; Muhammed Yuksel; Cigdem Arikan; Vivien Karl; Judith Helene Aberle; Stephan...
  20. forestglip

    [...] epipharynx in long COVID identifies SARS-CoV-2 signalling pathways and the therapeutic potential of epipharyngeal abrasive therapy, 2025, Nishi+

    Spatial transcriptomics of the epipharynx in long COVID identifies SARS-CoV-2 signalling pathways and the therapeutic potential of epipharyngeal abrasive therapy Kensuke Nishi, Shohei Yoshimoto, Takayuki Tanaka, Shoichi Kimura, Toshiyuki Tsunoda, Akira Watanabe, Kaori Teranaka, Yo Oguma, Hanako...
Back
Top Bottom